<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03045029</url>
  </required_header>
  <id_info>
    <org_study_id>TDE-PH-401</org_study_id>
    <nct_id>NCT03045029</nct_id>
  </id_info>
  <brief_title>ADAPT - A Patient Registry of the Real-world Use of Orenitram®</brief_title>
  <acronym>ADAPT</acronym>
  <official_title>ADAPT - A Patient Registry of the Real-world Use of Orenitram®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United Therapeutics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational, multicenter, patient registry to observe and assess the
      real-world use and tolerability of Orenitram (treprostinil). Patients who are newly initiated
      on Orenitram for the treatment of pulmonary arterial hypertension (PAH) or who transition
      from another prostacyclin therapy will be evaluated for 52 weeks to observe dosing regimens,
      titration schedules, prostacyclin-related adverse events (AEs), and clinical outcomes of
      interest.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 18, 2017</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>52 Weeks</target_duration>
  <primary_outcome>
    <measure>Real-world use and tolerability of Orenitram in new starts and prostacyclin transition patients</measure>
    <time_frame>Baseline to Week 52</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment-related outcomes collected by study sites during routine clinical care</measure>
    <time_frame>Baseline to Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development, timing, severity, and frequency of prostacyclin-related AEs</measure>
    <time_frame>Enrollment to Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of concomitant medications</measure>
    <time_frame>Baseline to Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for discontinuing Orenitram and information on clinical titration schedules implemented for transition to alternative prostacyclin therapies</measure>
    <time_frame>Enrollment to Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare resource utilization trends</measure>
    <time_frame>Baseline to Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life in PAH and treatment satisfaction</measure>
    <time_frame>Baseline to Week 52</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Oral treprostinil</arm_group_label>
    <description>Sustained-release oral tablets for three times daily (TID) administration in prostacyclin naive and prostacyclin transition patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral treprostinil</intervention_name>
    <description>Sustained-release oral tablets for TID administration</description>
    <arm_group_label>Oral treprostinil</arm_group_label>
    <other_name>Treprostinil diethanolamine</other_name>
    <other_name>Treprostinil diolamine</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients are eligible if they have been receiving Orenitram for less than or equal to 21
        days or plan to initiate Orenitram therapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient is newly prescribed on Orenitram, per the package insert indication, and
             plans to initiate therapy with this medication, or has been receiving Orenitram for 21
             or fewer days.

          2. The patient agrees to dosing, prostacyclin-related AE of interest record keeping,
             survey participation during designated time periods, and recording any medication
             changes and use for the duration of the study.

          3. The patient has the ability to answer surveys, use the diary in English, and has
             access to the internet.

        Exclusion Criteria:

          1. The patient has previously received Orenitram for more than 21 days.

          2. The patient is currently receiving epoprostenol therapy or has received epoprostenol
             within 30 days of enrollment (except if received during acute vasodilator testing).

          3. The patient is currently participating in an investigational drug or device study
             within 30 days of enrollment. Co-enrollment in other noninterventional studies is
             allowed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bucky Turpin</last_name>
    <phone>(919) 425-5492</phone>
    <email>bturpin@unither.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Derek Solum, PhD</last_name>
    <phone>(919) 425-8122</phone>
    <email>dsolum@unither.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Southern California - Keck Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anton Akulov</last_name>
      <phone>323-409-7594</phone>
      <email>anton.akulov@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Sivagini Ganesh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Paloma Medical Group</name>
      <address>
        <city>San Juan Capistrano</city>
        <state>California</state>
        <zip>92675</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina Abdo</last_name>
      <email>dina@palomamedical.com</email>
    </contact>
    <investigator>
      <last_name>Michael Rovzar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora Denver Cardiology Associates</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Washam</last_name>
      <phone>303-839-7789</phone>
      <email>Melinda.washam@healthonecares.com</email>
    </contact>
    <investigator>
      <last_name>Nampalli Vijay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Clinical Research Center</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Eagan</last_name>
      <email>eagancm@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Hassan Alnuaimat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Lung, Sleep, and Critical Care Specialists</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>33204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iris Orengo, RN</last_name>
      <phone>904-354-8200</phone>
      <email>Iris.Orengo@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Abubakr Bajwa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Florida Pulmonary Group, P.A.</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Foust</last_name>
      <email>sfoust@cfpulmonary.com</email>
    </contact>
    <investigator>
      <last_name>Syed Mobin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Miami Heart Specialists</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jojie Calderin</last_name>
      <phone>305-999-3301</phone>
      <phone_ext>110</phone_ext>
      <email>gcalderin@ampmrc.com</email>
    </contact>
    <investigator>
      <last_name>Javier Jimenez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norma Jean Barton</last_name>
      <phone>954-659-6213</phone>
      <email>bartonn2@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Jinesh Mehta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlanta Cardiology Associates, LLC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raykel Martin</last_name>
      <email>rmartin.ellipsis@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Demir Baykal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comprehensive Cardiovascular Care, LLC</name>
      <address>
        <city>Gurnee</city>
        <state>Illinois</state>
        <zip>60031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Smith</last_name>
      <email>researchcoordinator@C3Gurnee.com</email>
    </contact>
    <investigator>
      <last_name>Isaac Dor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Medical Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Telfair Hull</last_name>
      <phone>859-218-2880</phone>
      <email>alexandra.hull@uky.edu</email>
    </contact>
    <investigator>
      <last_name>David Booth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville Physicians Outpatient Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Hamlyn</last_name>
      <phone>502-852-8739</phone>
      <email>Joan.hamlyn@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Karim El-Kersh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mclaren Greater Lansing</name>
      <address>
        <city>Okemos</city>
        <state>Michigan</state>
        <zip>48864</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Wray Esckilsen</last_name>
      <phone>517-975-9424</phone>
      <email>katie.esckilsen@mclaren.org</email>
    </contact>
    <investigator>
      <last_name>Majid Mughal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital Troy</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Coleen Tessmar</last_name>
      <phone>248-964-8524</phone>
      <email>ctessmar@beaumont.edu</email>
    </contact>
    <investigator>
      <last_name>Samuel Allen, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sukhu Indrawattie</last_name>
      <email>sukhui1@mail.amc.edu</email>
    </contact>
    <investigator>
      <last_name>Boris Medarov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Puja Chadha</last_name>
      <phone>718-780-5906</phone>
      <email>puc9004@nyp.org</email>
    </contact>
    <investigator>
      <last_name>Ruth Minkin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pulmonary Health Physicians, PC</name>
      <address>
        <city>Fayetteville</city>
        <state>New York</state>
        <zip>13066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Gabris</last_name>
      <email>Victoria.Gabris@CNYLungs.com</email>
    </contact>
    <investigator>
      <last_name>Sherif El Bayadi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Islandia</city>
        <state>New York</state>
        <zip>11790</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Skarre</last_name>
      <phone>631-444-9033</phone>
      <email>jacqueline.skarre@stonybrookmedicine.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Strachan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pinehurst Medical Clinic, INC.</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Meyer</last_name>
      <email>rmeyer@pinehurstmedical.com</email>
    </contact>
    <investigator>
      <last_name>Michael Pritchett</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Padams</last_name>
      <phone>215-955-7410</phone>
      <email>patricia.a.padams@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Donna Carstens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anderson Pharmaceutical Research, LLC</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Parsons</last_name>
      <email>sparsons@vitallinkresearch.com</email>
    </contact>
    <investigator>
      <last_name>Charles Thompson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Biomedical Research</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37919</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krista Tibbs</last_name>
      <email>ktibbs@biomed-research.com</email>
    </contact>
    <investigator>
      <last_name>John Swisher</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Propps</last_name>
      <email>jessica.propps@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Mohammed Mogri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Renovatio Clinical</name>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <zip>77380</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maya Fleyhan</last_name>
      <email>maya.fleyhan@renovatioclinical.com</email>
    </contact>
    <investigator>
      <last_name>Wael Asi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart Care Associates, LLC</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelsey Krueger</last_name>
      <phone>414-649-5097</phone>
      <email>kelsey.krueger@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Dianne Zwicke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2017</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2017</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PAH</keyword>
  <keyword>Oral Treprostiinil</keyword>
  <keyword>Orenitram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Treprostinil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

